Article Details
Retrieved on: 2018-07-01 19:03:19
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Benchmark Capital</b> reported 1.01% of its portfolio in Sarepta Therapeutics, Inc. (NASDAQ:SRPT). Virtu Financial Limited owns 8,857 shares or 0.04% ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here